Financials data is unavailable for this security.
View more
Year on year Pediatrix Medical Group Inc had net income fall from a gain of 66.34m to a loss of 60.41m despite flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 81.88% to 84.02%.
| Gross margin | -- |
|---|---|
| Net profit margin | -12.65% |
| Operating margin | -11.93% |
| Return on assets | -11.53% |
|---|---|
| Return on equity | -29.85% |
| Return on investment | -13.80% |
More ▼
Cash flow in USDView more
In 2023, Pediatrix Medical Group Inc increased its cash reserves by 645.70%, or 63.43m. The company earned 137.33m from its operations for a Cash Flow Margin of 6.88%. In addition the company used 48.18m on investing activities and also paid 25.72m in financing cash flows.
| Cash flow per share | -2.63 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 8.53 |
|---|---|
| Tangible book value per share | -6.05 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.42 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.8556 |
|---|---|
| Total debt/total capital | 0.4611 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -198.80%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -387.82 |
